These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38491743)

  • 1. An update on clinical trials for cutaneous lupus erythematosus.
    Xie L; Lopes Almeida Gomes L; Stone CJ; Faden DF; Werth VP
    J Dermatol; 2024 Jul; 51(7):885-894. PubMed ID: 38491743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Litifilimab (BIIB059), a promising investigational drug for cutaneous lupus erythematosus.
    Cho SK; Vazquez T; Werth VP
    Expert Opin Investig Drugs; 2023 May; 32(5):345-353. PubMed ID: 37148249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging immunotherapeutic strategies for cutaneous lupus erythematosus: an overview of recent phase 2 and 3 clinical trials.
    Lim D; Kleitsch J; Werth VP
    Expert Opin Emerg Drugs; 2023 Dec; 28(4):257-273. PubMed ID: 37860982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus.
    Cho YM; Furie R
    Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for cutaneous disease in systemic lupus erythematosus.
    Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological therapies in the treatment of cutaneous lupus erythematosus.
    Presto JK; Hejazi EZ; Werth VP
    Lupus; 2017 Feb; 26(2):115-118. PubMed ID: 27687023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.
    Niebel D; de Vos L; Fetter T; Brägelmann C; Wenzel J
    Am J Clin Dermatol; 2023 Jul; 24(4):521-540. PubMed ID: 37140884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous Lupus Erythematosus: Progress and Challenges.
    Petty AJ; Floyd L; Henderson C; Nicholas MW
    Curr Allergy Asthma Rep; 2020 Apr; 20(5):12. PubMed ID: 32248318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel biological therapeutic approaches to cutaneous lupus erythematosus.
    Tayer-Shifman OE; Rosen CF; Wakani L; Touma Z
    Expert Opin Biol Ther; 2018 Oct; 18(10):1041-1047. PubMed ID: 30118337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Therapies in Cutaneous Lupus Erythematosus.
    Sprow G; Dan J; Merola JF; Werth VP
    Front Med (Lausanne); 2022; 9():968323. PubMed ID: 35899214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous and systemic connections in lupus.
    Maz MP; Michelle Kahlenberg J
    Curr Opin Rheumatol; 2020 Nov; 32(6):583-589. PubMed ID: 32826479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anifrolumab for treatment of refractory cutaneous lupus erythematosus.
    Blum FR; Sampath AJ; Foulke GT
    Clin Exp Dermatol; 2022 Nov; 47(11):1998-2001. PubMed ID: 35844070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging biologic therapies for systemic lupus erythematosus.
    Kato H; Kahlenberg JM
    Curr Opin Rheumatol; 2024 May; 36(3):169-175. PubMed ID: 38299618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.
    Chen KL; Krain RL; Werth VP
    F1000Res; 2019; 8():. PubMed ID: 30984372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expert Perspective: An Evidence-Based Approach to Refractory Cutaneous Lupus Erythematosus.
    Borucki R; Werth VP
    Arthritis Rheumatol; 2020 Nov; 72(11):1777-1785. PubMed ID: 32776469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.
    Foulke G; Helm LA; Clebak KT; Helm M
    FP Essent; 2023 Mar; 526():25-36. PubMed ID: 36913660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cutaneous lupus erythematosus: current approaches and future strategies.
    Shi H; Gudjonsson JE; Kahlenberg JM
    Curr Opin Rheumatol; 2020 May; 32(3):208-214. PubMed ID: 32141953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic approach and treatment of cutaneous lupus erythematosus.
    Sticherling M; Bonsmann G; Kuhn A
    J Dtsch Dermatol Ges; 2008 Jan; 6(1):48-59. PubMed ID: 18190433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment.
    Hejazi EZ; Werth VP
    Am J Clin Dermatol; 2016 Apr; 17(2):135-46. PubMed ID: 26872954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice.
    Patel J; Borucki R; Werth VP
    Curr Rheumatol Rep; 2020 Aug; 22(10):69. PubMed ID: 32845411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.